3.4
Impact Factor
4.9
CiteScore
23 days
Time to First Decision

Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..

Current Oncology, Volume 17, Issue 2

2010 April - 14 articles

Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
You may sign up for email alerts to receive table of contents of newly released issues.
PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (14)

Select all

Article

25 Citations

1,047 Views

5 Pages

Evaluation of Six Risk Factors for the Development of Bacteremia in Children with Cancer and Febrile Neutropenia

Juan Enrique Asturias,
J. E. Corral and
J. Quezada

Curr. Oncol.2010, 17(2), 59-63;https://doi.org/10.3747/co.v17i2.453

1 April 2010

Febrile neutropenia is a well-known entity in children with cancer, being responsible for the high risk for infection that characterizes this population. For this reason, cancer patients are hospitalized so that they can receive prophylactic care. Ri...

Full Article

Article

8 Citations

955 Views

7 Pages

Diagnosis and Management of Hepatocellular Carcinoma: Results of a Consensus Meeting of The Ottawa Hospital Cancer Centre

T. Asmis,
F. Balaa,
L. Scully,
D. Papadatos,
C. Marginean,
N. Fasih,
T. Shaw–Stiffel and
R. Goel

Curr. Oncol.2010, 17(2), 6-12;https://doi.org/10.3747/co.v17i2.555

1 April 2010

Hepatocellular carcinoma (HCC) is an uncommon tumour, but its incidence is increasing in Canada and elsewhere. Currently, there are no Canadian recommendations for diagnosis and treatment of HCC, and possible options may have regional limitations. A...

Full Article

Article

4 Citations

759 Views

5 Pages

One Year of Complete Clinical Response in a Metastatic Breast Cancer Patient Treated with a Combination of Lapatinib and Gemcitabine

J. M. Gasent Blesa,
J. Laforga Canales and
V. Alberola Candel

Curr. Oncol.2010, 17(2), 64-68;https://doi.org/10.3747/co.v17i2.422

1 April 2010

The treatment of metastatic breast cancer is challenging. We recently assisted in the development of targeted therapies (in combination with chemotherapy or as monotherapy) that have improved results for selected groups of patients. Lapatinib is a du...

Full Article

Article

10 Citations

964 Views

6 Pages

Feasibility of Administering Zoledronic Acid in Palliative Patients Being Cared for in the Community: Results of a Pilot Study

H.K. Marr,
C.R. Stiles,
M.A. Boyar,
T.C. Braun,
N.A. Hagen,
C. Janzen,
L.M. Whitten and
J.L. Pereira

Curr. Oncol.2010, 17(2), 69-74;https://doi.org/10.3747/co.v17i2.507

1 April 2010

Tumour-induced hypercalcemia (TIH) and pain from bone metastases are common complications of advanced malignancy and have a significant negative impact on quality of life. Many cancer patients in the advanced stages of their palliative illness prefer...

Full Article

of 2

Get Alerted

Add your email address to receive forthcoming issues of this journal.

Curr. Oncol. - ISSN 1718-7729

Imprint

Download Flyer